Bartolome R. Celli , Leonardo M. Fabbri , Abebaw M. Yohannes , Nathaniel M. Hawkins , Gerard J. Criner , Jessica Bon , Marc Humbert , Christine R. Jenkins , Leonardo Pantoni , Alberto Papi , Jennifer K. Quint , Sanjay Sethi , Daiana Stolz , Alvar Agusti , Don D. Sin
{"title":"A person-centred clinical approach to the multimorbid patient with COPD","authors":"Bartolome R. Celli , Leonardo M. Fabbri , Abebaw M. Yohannes , Nathaniel M. Hawkins , Gerard J. Criner , Jessica Bon , Marc Humbert , Christine R. Jenkins , Leonardo Pantoni , Alberto Papi , Jennifer K. Quint , Sanjay Sethi , Daiana Stolz , Alvar Agusti , Don D. Sin","doi":"10.1016/j.ejim.2025.07.020","DOIUrl":null,"url":null,"abstract":"<div><div>Most patients with a chronic disease are multimorbid. This is particularly important in patients with chronic obstructive pulmonary disease (COPD), who on average have five other identified comorbidities that independently impact their health and increase their mortality risk. Using a modified Delphi method, we selected the 20 most important diseases associated with COPD and clustered them into five domains: mental, respiratory, cardiovascular, metabolic and multiple organs loss of tissue. We then developed a systematic approach to characterise the impact and clinical presentation of individual diseases within each cluster, and to define the priority and timing of measurement of the potential markers of disease presence and severity. Given the absence of integrated guidelines to treat multimorbid patients, we reviewed and selected individual disease guidelines or recommendations that can be accessed for specific information related to the management of each disease. In addition, we built a multimorbidity ‘Health Dashboard’ that, completed by the patient or health practitioner, can help identify the presence and severity of comorbid diseases. By using a practical comprehensive approach, it is possible to identify and characterise important comorbid diseases in patients with COPD, and to implement management tools that should help improve their outcome. This expert consensus commentary summarises patient-centred recommendations to manage comorbidities in COPD patients, aiming to improve quality-of-life and reduce disease burden through a holistic approach. Prospective pragmatic trials comparing such an approach with usual care for multimorbid patients with COPD including long-term follow-up are urgently needed.</div></div>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":"140 ","pages":"Article 106424"},"PeriodicalIF":6.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0953620525003024","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Most patients with a chronic disease are multimorbid. This is particularly important in patients with chronic obstructive pulmonary disease (COPD), who on average have five other identified comorbidities that independently impact their health and increase their mortality risk. Using a modified Delphi method, we selected the 20 most important diseases associated with COPD and clustered them into five domains: mental, respiratory, cardiovascular, metabolic and multiple organs loss of tissue. We then developed a systematic approach to characterise the impact and clinical presentation of individual diseases within each cluster, and to define the priority and timing of measurement of the potential markers of disease presence and severity. Given the absence of integrated guidelines to treat multimorbid patients, we reviewed and selected individual disease guidelines or recommendations that can be accessed for specific information related to the management of each disease. In addition, we built a multimorbidity ‘Health Dashboard’ that, completed by the patient or health practitioner, can help identify the presence and severity of comorbid diseases. By using a practical comprehensive approach, it is possible to identify and characterise important comorbid diseases in patients with COPD, and to implement management tools that should help improve their outcome. This expert consensus commentary summarises patient-centred recommendations to manage comorbidities in COPD patients, aiming to improve quality-of-life and reduce disease burden through a holistic approach. Prospective pragmatic trials comparing such an approach with usual care for multimorbid patients with COPD including long-term follow-up are urgently needed.
期刊介绍:
The European Journal of Internal Medicine serves as the official journal of the European Federation of Internal Medicine and is the primary scientific reference for European academic and non-academic internists. It is dedicated to advancing science and practice in internal medicine across Europe. The journal publishes original articles, editorials, reviews, internal medicine flashcards, and other relevant information in the field. Both translational medicine and clinical studies are emphasized. EJIM aspires to be a leading platform for excellent clinical studies, with a focus on enhancing the quality of healthcare in European hospitals.